Work

Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation

Year: 2016

Type: article

Source: Tumor Biology

DOI: 10.1007/s13277-016-5290-9

Authors: Umesh T. Sankpal, Susan B. Ingersoll, Sarfraz Ahmad, Robert W. Holloway, Vadiraja B. Bhat, Jerry W. Simecka, Liz Daniel, Ekamber Kariali, Jamboor K. Vishwanatha, Riyaz Basha

Institutions: University of North Texas Health Science Center, Florida Hospital Cancer Institute, Agilent Technologies (United States), Sambalpur University

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Minority Health and Health Disparities

Award: Texas Center for Minority Health, Education, Research and Outreach

OpenAlex ID: W2515067541

FWCI: 5.763

Cites: 43

Cited by: 31

Related to: 10